Authors Dolfi B, Gallerand A, Firulyova MM, Xu Y, Merlin J, Dumont A, Castiglione A, Vaillant N, Quemener S, Gerke H, Stunault MI, Schrank PR, Kim SH, Zhu A, Ding J, Gilleron J, Magnone V, Barbry P, Dombrowicz D, Duranton C, Wakkach A, Blin-Wakkach C, Becher B, Pagnotta S, Argüello RJ, Rantakari P, Chakarov S, Ginhoux F, Zaitsev K, Kim KW, Yvan-Charvet L, Guinamard RR, Williams JW, Ivanov S
Cell reports Jun 2022
Recent advances in understanding the role of HES6 in cancers.Authors Krossa I, Strub T, Martel A, Nahon-Esteve S, Lassalle S, Hofman P, Baillif S, Ballotti R, Bertolotto C
Theranostics Jun 2022
Short-term Outcomes in a Nurse Coordinator-led and Nurse Practitioner-led Sotrovimab Initiative for Solid Organ Transplant Recipients During the Omicron Surge.Authors Cochran W, Langlee J, Barker L, Freed K, Brown A, McDade H, Carter D, Boyer L, Sullivan S, Shagena K, Belden M, Marino R, Adams E, Lee J, McCarthy M, Lee-Young K, Ellis S, Young S, Morrison M, Penny CC, Al Ammary F, Hartman L, Horn J, Miller T, Miller S, Purekal S, Siddiqui Z, Segev DL, Brennan DC, Shah P, Avery RK
Transplantation Jun 2022
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia.Authors Lin KH, Rutter JC, Xie A, Killarney ST, Vaganay C, Benaksas C, Ling F, Sodaro G, Meslin PA, Bassil CF, Fenouille N, Hoj J, Washart R, Ang HX, Cerda-Smith C, Chaintreuil P, Jacquel A, Auberger P, Forget A, Itzykson R, Lu M, Lin J, Pierobon M, Sheng Z, Li X, Chilkoti A, Owzar K, Rizzieri DA, Pardee TS, Benajiba L, Petricoin E, Puissant A, Wood KC
Nature cancer Jun 2022
Creating a new chapter in the DSM for late-onset depressive disorders.Authors Gerolymos C, Masson M, Lancon C, Richieri R, Boyer L, Fond G
L'Encephale Jun 2022
Association between metabolic disorders and seminal plasma miRNA levels: a pilot study.Authors Saget S, Kappeler L, Grandjean V, Leneuve P, Berthaut I, Faure C, Czernichow S, Racine C, Lévy R, Dupont C,
Basic and clinical andrology Jun 2022
Metastatic melanoma treated by immunotherapy: discovering prognostic markers from radiomics analysis of pretreatment CT with feature selection and classification.Authors Ungan G, Lavandier AF, Rouanet J, Hordonneau C, Chauveau B, Pereira B, Boyer L, Garcier JM, Mansard S, Bartoli A, Magnin B
International journal of computer assisted radiology and surgery Jun 2022
REDD1 is a gatekeeper of murine hematopoietic stem cell functions during stress responses.Authors Barroca V, Henry E, Dechamps N, Renou L, Chaintreuil P, Kulkarni R, Devanand S, Jacquel A, Robert G, Auberger P, Pflumio F, Arcangeli ML
Leukemia May 2022
Novel T Follicular Helper-like T-Cell Lymphoma Therapies: From Preclinical Evaluation to Clinical Reality.Authors Krug A, Tari G, Saidane A, Gaulard P, Ricci JE, Lemonnier F, Verhoeyen E
Cancers May 2022
Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity.Authors Bernard PL, Delconte R, Pastor S, Laletin V, Costa Da Silva C, Goubard A, Josselin E, Castellano R, Krug A, Vernerey J, Devillier R, Olive D, Verhoeyen E, Vivier E, Huntington ND, Nunes J, Guittard G
Journal for immunotherapy of cancer May 2022